CDCTF(CDCTF)
CDCTF
$20.55—Stale · unknown old
OTCMARKET • Last print unknown ago
$20.55—Stale · unknown old
No analyst ratings available
No analyst price targets available for CDCTF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $43.29B | $44.36B | $44.30B | $43.85B | $44.66B |
| Low | $43.15B | $43.34B | $43.72B | $43.27B | $44.07B |
| High | $43.44B | $45.37B | $44.89B | $44.43B | $45.25B |
| EBITDA Avg | $3.25B | $4.55B | $5.59B | $6.41B | $7.10B |
| Low | $3.25B | $4.55B | $5.59B | $6.41B | $7.09B |
| High | $3.25B | $4.55B | $5.59B | $6.41B | $7.10B |
| EBIT Avg | $679M | $669M | $666M | $667M | $667M |
| Low | $677M | $667M | $665M | $665M | $666M |
| High | $680M | $670M | $668M | $668M | $669M |
| Net Income Avg | $66M | $59M | $58M | $58M | $58M |
| Low | $65M | $58M | $57M | $57M | $57M |
| High | $67M | $60M | $59M | $59M | $59M |
| EPS Avg | $315.08 | $283.46 | $274.82 | $276.34 | $277.85 |
| Low | $309.67 | $278.59 | $270.10 | $271.59 | $273.08 |
| High | $320.50 | $288.33 | $279.54 | $281.08 | $282.63 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $5.08B | $11.72B | $9.19B |
| Low | $4.31B | $8.59B | $7.06B |
| High | $5.86B | $14.85B | $11.33B |
| EBITDA Avg | $599M | $738M | $782M |
| Low | $599M | $727M | $780M |
| High | $599M | $748M | $783M |
| EBIT Avg | $255M | $291M | $263M |
| Low | $255M | $281M | $261M |
| High | $256M | $301M | $264M |
| Net Income Avg | $-1M | $23M | $4M |
| Low | $-1M | $16M | $3M |
| High | $-749,139 | $31M | $5M |
| EPS Avg | $-5.25 | $114.78 | $20.51 |
| Low | $-6.84 | $80.08 | $14.31 |
| High | $-3.67 | $149.47 | $26.71 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |